No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Trump Administration Cancels Meeting With FDA Workers Union - Report
Novo Nordisk's Options: A Look at What the Big Money Is Thinking
Trump is at it again: reducing the approval time for domestic pharmaceutical companies in the USA.
Trump's obsession with the Industry Chain should not be underestimated!
Eli Lilly in Licensing Pact With Alchemab for ALS Program
Oric Pharmaceuticals Announces Clinical Trial Collaboration And Supply Agreement With Johnson & Johnson To Evaluate ORIC-114 In Combination With Subcutaneous Amivantamab For The First-Line Treatment Of NSCLC Patients With EGFR Exon 20 Insertion Mutations
Schwab Trading Activity Index Retreats to Two-year Low the Same Month Tariffs Announced
